Cargando…
Post COVID-19 vaccine deaths - Singapore’s early experience
Singapore has been using mRNA vaccines developed by Pfizer-BioNTech and Moderna as part of the nation’s COVID vaccination program since 30 December 2020. From 1 February 2021–30 June 2021, a total of 34 deaths that occurred within 72 h of the deceased receiving their COVID-19 vaccination were referr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767909/ https://www.ncbi.nlm.nih.gov/pubmed/35078041 http://dx.doi.org/10.1016/j.forsciint.2022.111199 |
_version_ | 1784634813315022848 |
---|---|
author | YEO, Audrey KUEK, Benjamin LAU, Mandy TAN, Shi Rui CHAN, Shijia |
author_facet | YEO, Audrey KUEK, Benjamin LAU, Mandy TAN, Shi Rui CHAN, Shijia |
author_sort | YEO, Audrey |
collection | PubMed |
description | Singapore has been using mRNA vaccines developed by Pfizer-BioNTech and Moderna as part of the nation’s COVID vaccination program since 30 December 2020. From 1 February 2021–30 June 2021, a total of 34 deaths that occurred within 72 h of the deceased receiving their COVID-19 vaccination were referred to the Forensic Medicine Division of the Health Sciences Authority of Singapore. Autopsies, histological sampling and ancillary investigations consisting of total tryptase level, Immunoglobulin E (IgE), and C-reactive Protein (CRP), were performed on 29 of these cases. Our study has shown no definite causative relationship between the mRNA vaccination and deaths of individuals who died within 72 h after receiving the vaccination, in particular with regards to anaphylactic reactions, myocarditis and pericarditis, and thrombotic complications. Further studies may consider increasing the incident time frame from 72 h to seven days post-vaccination or longer to include any potential delayed presentation of adverse effects. |
format | Online Article Text |
id | pubmed-8767909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87679092022-01-19 Post COVID-19 vaccine deaths - Singapore’s early experience YEO, Audrey KUEK, Benjamin LAU, Mandy TAN, Shi Rui CHAN, Shijia Forensic Sci Int Article Singapore has been using mRNA vaccines developed by Pfizer-BioNTech and Moderna as part of the nation’s COVID vaccination program since 30 December 2020. From 1 February 2021–30 June 2021, a total of 34 deaths that occurred within 72 h of the deceased receiving their COVID-19 vaccination were referred to the Forensic Medicine Division of the Health Sciences Authority of Singapore. Autopsies, histological sampling and ancillary investigations consisting of total tryptase level, Immunoglobulin E (IgE), and C-reactive Protein (CRP), were performed on 29 of these cases. Our study has shown no definite causative relationship between the mRNA vaccination and deaths of individuals who died within 72 h after receiving the vaccination, in particular with regards to anaphylactic reactions, myocarditis and pericarditis, and thrombotic complications. Further studies may consider increasing the incident time frame from 72 h to seven days post-vaccination or longer to include any potential delayed presentation of adverse effects. Elsevier B.V. 2022-03 2022-01-19 /pmc/articles/PMC8767909/ /pubmed/35078041 http://dx.doi.org/10.1016/j.forsciint.2022.111199 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article YEO, Audrey KUEK, Benjamin LAU, Mandy TAN, Shi Rui CHAN, Shijia Post COVID-19 vaccine deaths - Singapore’s early experience |
title | Post COVID-19 vaccine deaths - Singapore’s early experience |
title_full | Post COVID-19 vaccine deaths - Singapore’s early experience |
title_fullStr | Post COVID-19 vaccine deaths - Singapore’s early experience |
title_full_unstemmed | Post COVID-19 vaccine deaths - Singapore’s early experience |
title_short | Post COVID-19 vaccine deaths - Singapore’s early experience |
title_sort | post covid-19 vaccine deaths - singapore’s early experience |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767909/ https://www.ncbi.nlm.nih.gov/pubmed/35078041 http://dx.doi.org/10.1016/j.forsciint.2022.111199 |
work_keys_str_mv | AT yeoaudrey postcovid19vaccinedeathssingaporesearlyexperience AT kuekbenjamin postcovid19vaccinedeathssingaporesearlyexperience AT laumandy postcovid19vaccinedeathssingaporesearlyexperience AT tanshirui postcovid19vaccinedeathssingaporesearlyexperience AT chanshijia postcovid19vaccinedeathssingaporesearlyexperience |